References for: association

Full identifier: http://purl.org/np/RAgNJMmLQvi4W8OsxlMWanQdU5ccGxMOYjk-55-Fuit_k#association

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-15T15:58:27Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-15T15:58:27Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-15T15:58:27Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-15T15:58:27Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-15T15:58:27Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-15T15:58:27Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-15T15:58:27Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
leflunomide is indicated in adults for the treatment of active rheumatoid arthritis ra to reduce signs and symptoms to inhibit structural damage as evidenced by x ray erosions and joint space narrowing to improve physical function see clinical studies aspirin nonsteroidal anti inflammatory agents and or low dose corticosteroids may be continued during treatment with leflunomide see precautions drug interactions nsaids warnings immunosuppression potential bone marrow suppression
Leoni Bücken
2021-06-15T15:58:27Z